Vigil Neuroscience Inc (VIGL)

NASDAQ
7.68
-0.19(-2.41%)
After Hours
7.30
-0.38(-4.95%)
- Real-time Data
  • Volume:
    10,874
  • Day's Range:
    7.47 - 8.03
  • 52 wk Range:
    2.18 - 18.27

VIGL Overview

Prev. Close
7.87
Day's Range
7.47-8.03
Revenue
-
Open
7.8
52 wk Range
2.18-18.27
EPS
-3.87
Volume
10,874
Market Cap
217.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
57,543
P/E Ratio
-2.05
Beta
-
1-Year Change
-
Shares Outstanding
28,268,563
Next Earnings Date
Nov 30, 2022
What is your sentiment on Vigil Neuroscience?
or
Market is currently closed. Voting is open during market hours.

Vigil Neuroscience Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Vigil Neuroscience Inc Company Profile

Vigil Neuroscience Inc Company Profile

Employees
0

Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer’s disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellBuyBuyBuy
Technical IndicatorsSellStrong SellSellStrong BuyBuy
SummarySellStrong SellNeutralStrong BuyBuy